Chinmaya IAS Academy – Current Affairs Chinmaya IAS Academy – Current Affairs
Recently, the Ministry of Ayush launched its Ayush Clinical Case Repository (ACCR) portal and the third version of Ayush Sanjivani App in a virtual event.
Important points
- It is conceptualized and developed by the Ministry of Ayush as a platform to support both Ayush practitioners and the public.
- It welcomes Ayush practitioners from all over the world to enrol and share information about successfully treated cases for the benefit of all.
- Cases whose details are posted here will be screened by experts, and will be uploaded for all to read/view subject to their review.
- To portray the strengths of Ayush systems for treatment of various disease conditions.
- It is developed by the Ministry of Ayush and the Ministry of Electronics and Information Technology (MeitY).
- First version was launched in May 2020.
- It targets to reach out to 50 lakh people in the country.
- The app intends to generate data on usage of AYUSH (Ayurveda, Yoga & Naturopathy, Unani, Siddha, Sowa-rigpa and Homoeopathy) advocacies and measures among the population and its impact in prevention of Covid-19
- To understand the measures adopted by the public for enhancing immunity and keeping themselves healthy in difficult Covid-19 situations.
- Data analyzed will be helpful for the further development of Ayush Systems.
Benefits:
- It will facilitate a significant study and documentation regarding the efficacy of selected Ayush interventions, including Ayush 64 and Kabasura Kudineer medicines in the management of asymptomatic and mild to moderate Covid-19 patients.
- Ayush 64 is a poly-herbal formulation developed by the Central Council for Research in Ayurvedic Sciences (CCRAS). It is useful in the treatment of asymptomatic, mild and moderate Covid-19 infection as an adjunct to standard care.
- Initially the drug was developed for Malaria in the year 1980 and now is repurposed for Covid-19.
- Kabasura Kudineer is a traditional formulation used by Siddha practitioners for effectively managing common respiratory health.
SOURCE: THE HINDU,THE ECONOMIC TIMES,MINT
